Celebrities discuss GLP-1 weight loss drugs, sharing results, struggles, and revealing side effects and mental costs ...

A new study suggests GLP-1 weight-loss drugs – such as Ozempic – might affect medical imagining scans and interfere with doctors’ ability to detect diseases.

GLP-1 drugs such as Ozempic are accelerating interest in protein to address the loss of lean muscle mass that can accompany ...

This 3-part series looks at the evidence for the treatment of SUDs reviews & the use of GLP-1 receptor agonists and alcohol use disorder.

GLP-1 receptor agonists have shown promise as treatment for addiction, but there are still several hurdles affecting their ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

Evolv has launched a supplement featuring yeast engineered to produce a peptide that engages GLP-1 receptors, with a ...

The jabs side effects have been widely discussed, ranging from nausea to even organ damage. Now, doctors have warned it may ...

New research found that eating breakfast later signals health problems in older adults, prompting questions about the best time to eat breakfast.

Ozempic, containing semaglutide, aids weight loss and diabetes management while offering cardiovascular and kidney protection ...

The uptake of GLP-1 drugs is extraordinary. Everyone is either taking them, considering taking them, or knows someone else who has. And it’s this speed of adoption that’s powered the global market to ...

Dutch fermentation startup The Protein Brewery has raised €30M ($35M) in Series B funding to bring its fungi-derived Fermotein ingredient to market. It’s also closing in on European approval.